Literature DB >> 18367285

Lanreotide Autogel for persistent diabetic macular edema.

Maria C Hernaez-Ortega1, Enrique Soto-Pedre, José A Piniés.   

Abstract

Diffuse diabetic macular edema is usually refractory to conventional treatment. We investigated the effectiveness of a new prolonged lanreotide formulation in patients with bad-controlled diabetes and persistent cystoid macular edema. Our findings suggest that monthly subcutaneous injections of lanreotide Autogel offered an effective treatment alternative in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367285     DOI: 10.1016/j.diabres.2008.02.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1 in total

Review 1.  Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives.

Authors:  Cristina Hernández; Olga Simó-Servat; Rafael Simó
Journal:  Endocrine       Date:  2014-03-14       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.